Immunotherapy 2.0 is ASCO’s Cancer Advance of the Year – Curetoday.com
Curetoday.com |
Immunotherapy 2.0 is ASCO's Cancer Advance of the Year
Curetoday.com With five agents approved in 2016 alone, immunotherapy continues to revolutionize the treatment paradigms for a number of different cancers. Recognizing the impact that these agents have had over the past year, the American Society of Clinical Oncology … Report: Trump Administration Should Continue Funding Cancer Research |
